This advanced MVA manufacturing process is expected to significantly simplify vaccine production, particularly in middle- and low-income regions where supply chain issues often hinder access to ...

In principle, mRNA vaccines are ideal for health emergencies as they can be quickly mass produced using a template. The problem is that current cell-based template production methods take too long, ...

Continuous manufacturing (CM) has become a contentious topic in the modern pharmaceutical lexicon, driven by divergent ...

which is now in the process of catching up.-Timothy Mercer, University of Queensland For Mercer, bringing sequencing methods into that ecosystem was an intuitive solution for improving quality control ...

So Medicago, a clinical-stage biopharmaceutical company located in Quebec, Canada, is harnessing a plant-based transient expression process ... of our vaccine and therapeutic protein production ...

This site is earmarked for the construction of an end-to-end vaccine manufacturing facility, showcasing Kenya's commitment to healthcare advancement. In 2022, Kenya initiated the process of ...

Meiji Seika Pharma Receives Approval for Adding Domestic Manufacturing Sites in Japan for KOSTAIVE®, a Self-amplifying mRNA Vaccine Against COVID-19 Meiji Seika Pharma Co., Ltd. (Headquarters ...

Africa is taking major steps toward self-sufficiency in vaccine and health product manufacturing, as leaders, manufacturers, and global partners gathered at the 2nd Vaccine & Health Products ...

GeoVax Advanced MVA Manufacturing Process: Aimed to Enhance Vaccine Supply Worldwide 27.01.2025 / 15:04 CET/CEST The issuer is solely responsible for the content of this announcement. Process ...